Peptide Sequence: human CysLT1 receptor amino acids 318-337 (TYVPRKKASLPEKGEEICKV) To be used in conjunction with Cayman&rsquos CysLT1 receptor polyclonal antibody (Catalog No. 120500) to block protein-antibody complex formation during analysis for
Peptide Sequence: human CysLT1 receptor amino acids 318-337 (TYVPRKKASLPEKGEEICKV) To be used in conjunction with Cayman&rsquos CysLT1 receptor polyclonal antibody (Catalog No. 120500) to block protein-antibody complex formation during analysis for
Peptide sequence: human PPAR&alpha amino acids 22-36 (PLSEEFLQEMGNIQE) To be used in conjunction with Cayman&rsquos PPAR&alpha polyclonal antibody (Catalog No. 101710) to block protein-antibody complex formation during analysis for PPAR&alpha.
Peptide sequence: human PPAR&alpha amino acids 22-36 (PLSEEFLQEMGNIQE) To be used in conjunction with Cayman&rsquos PPAR&alpha polyclonal antibody (Catalog No. 101710) to block protein-antibody complex formation during analysis for PPAR&alpha.
Peptide Sequence: human optineurin amino acids 115-130 (KGKSERSSEDPTDDSR) To be used in conjunction with Cayman&rsquos optineurin (INT) polyclonal antibody (Catalog No. 100002) to block protein-antibody complex formation during analysis of
Peptide Sequence: human optineurin amino acids 115-130 (KGKSERSSEDPTDDSR) To be used in conjunction with Cayman&rsquos optineurin (INT) polyclonal antibody (Catalog No. 100002) to block protein-antibody complex formation during analysis of
The peptide is identical among human, mous, and rat optineurin, amino acids 559-575 (GEVLPDIDTLQIHVMDC). This blocking peptide can be used in conjunction with Cayman&rsquos Optineurin (C-Term) Polyclonal Antibody (Catalog No.
The peptide is identical among human, mous, and rat optineurin, amino acids 559-575 (GEVLPDIDTLQIHVMDC). This blocking peptide can be used in conjunction with Cayman&rsquos Optineurin (C-Term) Polyclonal Antibody (Catalog No.
A macrolactam that binds to macrophilin-12 and inhibits calcineurin as well as prolyl isomerase the activation of T cells by allogeneic dendritic cells (IC<sub>50</sub> = 0.55 nM) and suppresses the generation of pro-inflammatory cytokines used in
A macrolactam that binds to macrophilin-12 and inhibits calcineurin as well as prolyl isomerase the activation of T cells by allogeneic dendritic cells (IC<sub>50</sub> = 0.55 nM) and suppresses the generation of pro-inflammatory cytokines used in
A benzylidene lactam compound that prevents the synthesis of inducible Hsps Hsp105, Hsp72, and Hsp40 at 100 &muM, inhibits the development of thermotolerance in COLO 320 DM cells.
A benzylidene lactam compound that prevents the synthesis of inducible Hsps Hsp105, Hsp72, and Hsp40 at 100 &muM, inhibits the development of thermotolerance in COLO 320 DM cells.
A hydroxyethyl ether rapamycin derivative that inhibits mTOR signaling through both mTORC1 and mTORC2 when added to cells at 20 nM orally available with superior pharmacokinetics and pharmacodynamics over rapamycin.
A hydroxyethyl ether rapamycin derivative that inhibits mTOR signaling through both mTORC1 and mTORC2 when added to cells at 20 nM orally available with superior pharmacokinetics and pharmacodynamics over rapamycin.
A selective, irreversible inhibitor of cytochrome P450 (CYP) 3A isoforms (IC<sub>50</sub> values range from 26 to 240 nM for CYP3A4 and CYP3A4/5 from different sources) potently blocks the hydroxylation of testosterone and midazolam by CYP3A4.
A selective, irreversible inhibitor of cytochrome P450 (CYP) 3A isoforms (IC<sub>50</sub> values range from 26 to 240 nM for CYP3A4 and CYP3A4/5 from different sources) potently blocks the hydroxylation of testosterone and midazolam by CYP3A4.
A benzylidene lactam compound that prevents the synthesis of inducible Hsps Hsp105, Hsp72, and Hsp40 at 100 &muM, inhibits the development of thermotolerance in COLO 320 DM cells.
A benzylidene lactam compound that prevents the synthesis of inducible Hsps Hsp105, Hsp72, and Hsp40 at 100 &muM, inhibits the development of thermotolerance in COLO 320 DM cells.